Last updated on August 2020

A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in participants with moderately to severely active Crohn's disease (CD).

Clinical Study Identifier: NCT03105128

Find a site near you

Start Over

SIH Research, LLC /ID# 163082

Kissimmee, FL United States
  Connect »

Alliance Medical Research /ID# 163840

Lighthouse Point, FL United States
  Connect »

ITB Research /ID# 161334

Miami, FL United States
  Connect »

Advanced Research Institute /ID# 161959

New Port Richey, FL United States
  Connect »

IMIC Inc. /ID# 154943

Palmetto Bay, FL United States
  Connect »

Delricht Research /ID# 206542

New Orleans, LA United States
  Connect »

NY Scientific /ID# 158418

Brooklyn, NY United States
  Connect »

Univ NC Chapel Hill /ID# 154840

Chapel Hill, NC United States
  Connect »

Tri-State Endoscopy /ID# 154933

Cincinnati, OH United States
  Connect »

Hightower Clinical /ID# 211938

Oklahoma City, OK United States
  Connect »

Gastro One /ID# 154742

Germantown, TN United States
  Connect »

Sagact Pllc /Id# 168770

San Antonio, TX United States
  Connect »

McGuire DV AMC /ID# 159990

Richmond, VA United States
  Connect »

City Clinical Hospital # 31 /ID# 208866

St. Petersburg, Russian Federation
  Connect »

Dr Eduan Deetlefs /ID# 158117

Cape Town,Milnerton, South Africa
  Connect »